Insider Selling: Crescent Capital BDC (NASDAQ:CCAP) Major Shareholder Sells $108,793.69 in Stock

Crescent Capital BDC, Inc. (NASDAQ:CCAP) major shareholder & Guaranty Life Insur Fidelity sold 10,471 shares of the stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $10.39, for a total value of $108,793.69. Following the completion of the transaction, the insider directly owned 3,945,797 shares of the company’s stock, valued at approximately $40,996,830.83. The trade was a 0.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

& Guaranty Life Insur Fidelity also recently made the following trade(s):

• On Wednesday, September 9th, & Guaranty Life Insur Fidelity sold 139,054 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.23, for a total value of $1,422,522.42.
• On Tuesday, September 8th, & Guaranty Life Insur Fidelity sold 126,436 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.33, for a total value of $1,306,083.88.
• On Thursday, September 3rd, & Guaranty Life Insur Fidelity sold 5,011 shares of Crescent Capital BDC stock. The stock was sold at an average price of $10.34, for a total value of $51,813.74.
• On Wednesday, September 2nd, & Guaranty Life Insur Fidelity sold 45,000 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.44, for a total value of $469,800.00.
• On Tuesday, September 1st, & Guaranty Life Insur Fidelity sold 11,285 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.50, for a total transaction of $118,492.50.
• On Monday, August 31st, & Guaranty Life Insur Fidelity sold 40,000 shares of Crescent Capital BDC stock. The stock was sold at an average price of $10.62, for a total transaction of $424,800.00.
• On Friday, August 28th, & Guaranty Life Insur Fidelity sold 15,000 shares of Crescent Capital BDC stock. The stock was sold at an average price of $10.60, for a total transaction of $159,000.00.
• On Thursday, August 27th, & Guaranty Life Insur Fidelity sold 27,195 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.60, for a total transaction of $288,267.00.
• On Wednesday, August 26th, & Guaranty Life Insur Fidelity sold 32,091 shares of Crescent Capital BDC stock. The shares were sold at an average price of $10.60, for a total transaction of $340,164.60.

Crescent Capital BDC Price Performance

Shares of Crescent Capital BDC stock opened at $9.93 on Friday. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 1.41. The stock has a market capitalization of $365.92 million, a price-to-earnings ratio of -110.33 and a beta of 0.52. Crescent Capital BDC, Inc. has a 1-year low of $9.88 and a 1-year high of $15.86. The firm’s 50-day moving average price is $10.91 and its two-hundred day moving average price is $11.83.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $37.12 million. Crescent Capital BDC had a positive return on equity of 9.02% and a negative net margin of 2.02%. On average, equities analysts predict that Crescent Capital BDC, Inc. will post 1.51 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 13.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is currently -1,511.11%.

Analyst Ratings Changes

Several analysts have recently commented on CCAP shares. B. Riley Financial decreased their target price on Crescent Capital BDC from $13.50 to $12.50 and set a “neutral” rating on the stock in a report on Wednesday, August 12th. Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $12.00 price target (down from $13.00) on shares of Crescent Capital BDC in a research report on Monday, August 17th. Oppenheimer lowered shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $19.00 to $16.00 in a report on Friday, May 15th. Wells Fargo & Company lowered their price objective on shares of Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 12th. Finally, Bank of America reaffirmed a “neutral” rating and issued a $10.25 target price (down from $13.00) on shares of Crescent Capital BDC in a research note on Thursday. One research analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $12.62.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Ieq Capital LLC boosted its stake in Crescent Capital BDC by 3.0% during the 4th quarter. Ieq Capital LLC now owns 25,470 shares of the company’s stock worth $358,000 after acquiring an additional 746 shares during the last quarter. Mariner LLC grew its holdings in Crescent Capital BDC by 0.3% during the fourth quarter. Mariner LLC now owns 451,774 shares of the company’s stock valued at $6,369,000 after purchasing an additional 1,492 shares during the period. Northwestern Mutual Wealth Management Co. bought a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $27,000. LMG Wealth Partners LLC raised its holdings in Crescent Capital BDC by 17.8% in the first quarter. LMG Wealth Partners LLC now owns 13,548 shares of the company’s stock worth $165,000 after purchasing an additional 2,048 shares during the period. Finally, NewEdge Advisors LLC raised its holdings in Crescent Capital BDC by 20.2% in the fourth quarter. NewEdge Advisors LLC now owns 12,279 shares of the company’s stock worth $173,000 after purchasing an additional 2,066 shares during the period. 49.46% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Crescent Capital BDC continues to offer a $0.34 quarterly dividend, equivalent to $1.36 annually and a yield of roughly 13%. The dividend may provide income support, although the company’s reported earnings and payout-ratio figures raise questions about sustainability. Dividend and company update
• Neutral Sentiment: Reported short interest was zero shares as of September 10, unchanged from the prior period. This implies no meaningful short-covering or short-selling pressure and makes the data largely irrelevant to the current move.
• Negative Sentiment: Bank of America downgraded CCAP from Buy to Neutral and cut its price target from $13 to $10.25. The revised target offers only about 3.2% upside from the stock’s reported $9.93 level, signaling limited near-term appreciation potential. Bank of America downgrade
• Negative Sentiment: Major shareholder Guaranty Life Insurance Fidelity has sold more than 300,000 shares in a series of recent transactions, including sales valued at approximately $1.31 million and $1.42 million on September 8 and 9. The trades were executed under a Rule 10b5-1 plan, which reduces their signaling value, but the persistent selling can still weigh on investor sentiment. Major shareholder sales
• Negative Sentiment: The company’s latest quarterly results missed consensus expectations, with earnings per share of $0.36 versus $0.37 expected. Reported revenue of $5.12 million was also well below the $37.12 million analyst estimate, adding to concerns about operating performance and earnings quality.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.